Method for synthesizing 2-bromoglutaric acid diester
A novel process for synthesizing 2-bromoglutaric acid diesters using butyrolactonic acid and hydrobromic acid achieves high yields and purities, addressing stability and reactivity issues in existing methods, suitable for pharmaceutical compounds like gadopiclenol.
Patent Information
- Application Number
- JP2023502679
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-07-16
- Filing Date
- 2021-07-16
- Publication Date
- 2026-02-03
- Estimated Expiration
- 2041-07-16
AI Technical Summary
Existing methods for synthesizing diethyl 2-bromoglutarate (EBG) are unstable and lack sufficient reactivity, while chloro derivatives are not suitable due to low reactivity, and iodo derivatives are less stable, necessitating a more stable and reactive alternative for industrial-scale synthesis of compounds like gadopiclenol.
A process involving the reaction of butyrolactonic acid with an alcohol in the presence of an acid to form a 2-hydroxyglutaric acid diester, followed by bromination with gaseous hydrobromic acid, yielding 2-bromoglutaric acid diesters with high purity and stability.
The process achieves 2-bromoglutaric acid diesters with yields over 85% and purities exceeding 90%, suitable for pharmaceutical applications.
Smart Images

Figure 0007810695000023 
Figure 0007810695000001 
Figure 0007810695000002
Abstract
Description
[Technical Field]
[0001] The present invention relates to a novel process for preparing 2-bromoglutaric acid diesters. [Background technology]
[0002] α-Haloglutaric acids and their esters are useful basic building blocks in organic synthesis, allowing the incorporation of α-glutaric acid fragments into complex molecules via simple nucleophilic substitution reactions.
[0003] EP 1 931 673 describes novel gadolinium complexes derived from PCTA, which are useful as contrast agents in medical imaging. Some of these complexes, particularly gadopiclenol, contain an α-glutaric acid fragment in the side chain. The synthesis of gadopiclenol (in the form of a mixture of all its stereoisomers) described in EP 1 931 673 involves alkylating picrene with diethyl 2-bromoglutarate, resulting in an intermediate hexaester, which is then hydrolyzed to the corresponding hexaacid, which is then complexed with a gadolinium source. Gadopiclenol prepared according to the process described in EP 1 931 673 is finally obtained by reacting the gadolinium hexaacid complex with 3-amino-1,2-propanediol. [ka]
[0004] Diethyl 2-bromoglutarate (hereafter referred to as EBG) is a relatively unstable compound that decomposes over time under the influence of temperature or in the presence of water. More specifically, this particular α-haloglutarate ester is prone to hydrolysis or cyclization, thereby losing a bromine atom. Attempts have been made to purify commercial EBG or to develop new synthetic routes to obtain it with improved purity or to prevent its decomposition, but have not yet been successful.
[0005] Therefore, the present inventors have been searching for an alternative to EBG that is more stable than EBG and at the same time sufficiently reactive to achieve the synthesis of, for example, gadopiclenol. Therefore, chloro derivatives of glutaric acid, which meet the criteria of improved stability compared to EBG, are not satisfactory substitutes because they lack sufficient reactivity. Iodo derivatives, by themselves, are more reactive than their bromo analogues, but are also less stable. The exploratory work carried out by the present inventors allowed the selection of di-(C3-C6)-alkyl 2-bromoglutarate compounds as alternatives to EBG, particularly in the synthesis of gadopiclenol. However, the corresponding commercially available products do not have a sufficiently high level of purity for use in the preparation of pharmaceutical products, such as gadopiclenol, intended for human administration. Summary of the Invention [Problem to be solved by the invention]
[0006] Therefore, there is a need to develop a new process for preparing di-(C3-C6)-alkyl 2-bromoglutarate compounds that can be obtained with a sufficient level of purity and can be efficiently carried out on an industrial scale.
[0007] To date, the synthesis of 2-bromoglutaric acid diesters has been described very rarely in the literature. To the best of our knowledge, Czechoslovak Patent No. 209266 B1 (granted in 1983) is the only document that describes the preparation of these compounds. It generally relates to a process for preparing α-haloglutaric acid or its alkyl diesters of formula R'OCCHCHCHCH(X)COR" (where R' and R" are (C1-C5) alkyl groups and X corresponds to a bromine or chlorine atom), but the emphasis there is clearly on the preparation of chloro derivatives, which can be obtained by chlorinating glutaric acid diesters in the presence of an antimony-based catalyst. Although the document asserts that the described method allows monochlorination at the α-position to be carried out with better selectivity than in prior art processes, the fact remains that considerable amounts of β-chloro or α-dichloro and trichloro derivatives are formed, with the selectivity for the α-monochloro reaction product ranging from 63.16% to 86.1%, depending on the identity of the antimony-based catalyst, and the conversion level of the starting ester itself varying between 86.10% and 98.9%. It should be noted that under conditions of highest conversion level of the starting material, the α-monochloro reaction product is obtained with a selectivity of only 79%. Another serious drawback of this process is the use of highly toxic antimony. [Means for solving the problem]
[0008] Thus, the present invention relates to a process for preparing 2-bromoglutaric acid diesters of formula (I): [ka] [wherein R represents a (C3-C6) alkyl group] This involves the following steps: (b) reacting a butyrolactonic acid of formula (BA) with an alcohol of formula ROH in the presence of an acid, such as sulfuric acid, to form a 2-hydroxyglutaric acid diester of formula (II); [ka] [ka] and (c) brominating the 2-hydroxyglutaric acid diester of formula (II) to the 2-bromoglutaric acid diester of formula (I) by sparging with gaseous hydrobromic acid.
[0009] For the purposes of the present invention, the term "(C3-C6) alkyl group" means a linear or branched saturated hydrocarbon-based chain having 3 to 6 carbon atoms. Examples include propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, pentyl, or hexyl groups, especially the n-butyl group (also called butyl).
[0010] Butyrolactonic acid of formula (BA) is also called carboxy-γ-butyrolactone.
[0011] In one preferred embodiment, R corresponds to a butyl group and the process according to the invention makes it possible to prepare dibutyl 2-bromoglutarate (also called dibutyl 2-bromo-1,5-pentanedioate (CAS No: 104867-13-2)) of formula (BBG). [ka]
[0012] In one specific embodiment, the process according to the invention comprises a first step (a) of reacting L-glutamic acid with sodium nitrite in an aqueous solution to form butyrolactonic acid of formula (BA).
[0013] Step (a) The first step consists of forming butyrolactonic acid (BA) from the commonly available starting material, L-glutamic acid, by reactions well known to those skilled in the art.
[0014] L-glutamic acid is introduced into water, the ratio of the mass of water used to the mass of L-glutamic acid introduced being typically greater than 1, in particular greater than 1.5, typically equal to 2. The density of water is equal to 1 g / mL, and in the following description, such a ratio of the mass of water (or, analogously, any other solvent or solution) to the mass of the solute will be expressed in terms of "volume equivalent" or, as an abbreviation, "vol.eq."
[0015] The water used in this process is preferably at least of the same quality as deionized water to avoid the formation of impurities such as α-chloro impurities, and in particular it may be deionized water or water for injection (WFI).
[0016] The aqueous solution so obtained is then typically heated, with stirring, to a temperature advantageously between 40°C and 70°C, in particular between 45°C and 65°C, preferably between 50°C and 60°C, especially 55°C.
[0017] Next, while maintaining the previously set temperature, the aqueous sodium nitrite solution is gradually added to the L-glutamic acid solution, preferably with stirring.
[0018] The amount of water used in the aqueous sodium nitrite solution is, for example, 0.8 to 5.0 vol.eq., particularly 1.0 to 3.0 vol.eq., and typically 2 vol.eq., based on the mass of sodium nitrite contained therein.
[0019] Sodium nitrite is preferably introduced into the L-glutamic acid solution in a slight excess over the stoichiometric ratio, so that the ratio of the amount of substance introduced as sodium nitrite to the amount of substance initially introduced as L-glutamic acid is greater than 1, but typically less than 1.5, in particular less than 1.3, and advantageously less than 1.2. In other words, the amount of sodium nitrite introduced is greater than 1 molar equivalent (mol.eq.), but typically less than 1.5 mol.eq., in particular less than 1.3 mol.eq., and advantageously less than 1.2 mol.eq., based on the amount of L-glutamic acid initially introduced (which itself corresponds to 1 molar equivalent).
[0020] The reaction mixture containing sodium nitrite and L-glutamic acid is then maintained under stirring, typically for a period of time until the various compounds present in the solution are dissolved, typically between 2 hours and 10 hours, preferably between 2 hours and 5 hours, advantageously at a temperature between 40°C and 70°C, particularly between 45°C and 65°C, preferably between 50°C and 60°C, especially at 55°C.
[0021] It is then cooled to a temperature advantageously between 10°C and 45°C, preferably between 10°C and 35°C, in particular between 15°C and 30°C, preferably between 20°C and 25°C, and then neutralized by adding an acid, for example a solution of preferably 33% m / m hydrochloric acid, wherein the amount of substance introduced as hydrochloric acid is close to, or typically equal to, therefore more than 1 molar equivalent (mol.eq.), but typically less than 1.5 mol.eq., in particular less than 1.3 mol.eq., advantageously less than 1.2 mol.eq., based on the amount of L-glutamic acid initially introduced.
[0022] The reaction mixture so neutralised is then typically concentrated under vacuum by gradually increasing the temperature up to a maximum temperature above 50°C, for example 60°C.
[0023] In the following description, the expression "under vacuum" refers to a pressure between 10 and 500 mbar, in particular between 10 and 350 mbar, preferably between 10 and 150 mbar, in particular between 50 and 100 mbar, the temperature being specified accordingly.
[0024] With regard to the vacuum concentration operation to obtain crude butyrolactonic acid (BA) upon completion of step (a), this is typically carried out at a pressure of less than 100 mbar and by gradually increasing the temperature until it reaches 60°C.
[0025] Steps (a) and (b) are preferably carried out in a one-pot embodiment, ie without intermediate steps of isolation or purification.
[0026] Step (b) Step (b) aims at forming a 2-hydroxyglutaric acid diester of formula (II) by reacting a butyrolactonic acid of formula (BA) with an alcohol of formula ROH. [ka]
[0027] In one preferred embodiment, butyrolactonic acid (BA) is obtained from step (a) above and is then employed in step (b) without purification.
[0028] During this step, the ring opening of the lactone and the generation of two ester functional groups -C(O)OR occur either in parallel or sequentially.
[0029] The alcohol ROH is preferably introduced in excess relative to the butyrolactonic acid. The amount of ROH introduced is therefore preferably equal to at least 2 molar equivalents (mol.eq.), in particular at least 4 mol.eq., advantageously between 2 and 10 mol.eq., in particular between 4 and 10 mol.eq., typically 5 mol.eq., based on the amount of butyrolactonic acid initially introduced. It should be noted that when butyrolactonic acid is obtained from step (a), the amount of ROH introduced is expressed relative to the amount of L-glutamic acid initially introduced, the mol.eq. being shown unchanged.
[0030] In one preferred embodiment, step (b) is carried out in the presence of an acetate of formula CH3COOR, wherein the amount of acetate introduced is typically between 0.1 and 0.7 mol eq., in particular between 0.2 and 0.5 mol eq., advantageously between 0.3 and 0.4 mol eq., based on the amount of alcohol ROH introduced.
[0031] The formation of the two ester functional groups -C(O)OR during step (b) can be advantageously carried out by acid catalysis. Therefore, step (b) is preferably carried out in the presence of a catalytic amount of an acid, such as sulfuric acid. Under such conditions, the lactone readily undergoes ring-opening to form 2-hydroxyglutaric acid of formula (HG), followed by esterification of the carboxylic acid functional group with the alcohol ROH. [ka]
[0032] Thus, step (b) of the process according to the invention further comprises the reaction of 2-hydroxyglutaric acid of formula (HG) with an alcohol of formula ROH to produce a 2-hydroxyglutaric acid diester of formula (II).
[0033] Conversely, butyrolactonic acid (BA) can undergo a first esterification reaction before ring-opening to form an esterified lactone of formula (BR): [ka]
[0034] Thus, step (b) of the process according to the invention further comprises the reaction of the esterified lactone of formula (BR) with an alcohol of formula ROH to produce a 2-hydroxyglutaric acid diester of formula (II).
[0035] It will be clear to one skilled in the art that the process according to the invention can also be carried out using 2-hydroxyglutaric acid of formula (HG) or an esterified lactone of formula (BR) as starting material for step (b) instead of butyrolactonic acid (BA).
[0036] In one preferred embodiment, the water present in the reaction mixture of step (b), typically produced in situ, is removed by vacuum distillation until a reaction medium is obtained having a mass fraction of water of less than 2% (w / w), preferably less than 1.5% (w / w), advantageously less than 0.8% (w / w).
[0037] Said reaction mixture of step (b) further comprises, inter alia, a butyrolactonic acid of formula (BA), an alcohol of formula ROH, and advantageously an acetic acid ester of formula CH3COOR.
[0038] Advantageously, the vacuum distillation is a vacuum azeotropic distillation.
[0039] For the purposes of the present invention, the term "vacuum azeotropic distillation" means the distillation of an azeotrope carried out at a pressure between 10 and 500 mbar, in particular between 10 and 350 mbar, preferably between 10 and 150 mbar, in particular between 50 and 100 mbar, which makes it possible to remove one of the components of the azeotrope.
[0040] In the present case, the azeotrope is a ternary azeotrope of water / ROH / CH3COOR, and the vacuum azeotropic distillation makes it possible to remove water from the mixture.
[0041] In one preferred embodiment, R corresponds to a butyl group (Bu) and the azeotrope is a ternary mixture of water / BuOH / CH3COOBu, characterized by a boiling point at atmospheric pressure between 85°C and 95°C, more precisely between 87°C and 93°C, even more precisely between 89°C and 91.5°C, typically equal to 89.4°C.
[0042] The vacuum azeotropic distillation of the ternary mixture water / BuOH / CH3COOBu is typically carried out at pressures between 10 and 500 mbar, in particular between 10 and 350 mbar, preferably between 10 and 150 mbar, in particular between 50 and 125 mbar, and at temperatures between 20°C and 100°C, in particular between 30°C and 70°C.
[0043] In one preferred embodiment, upon completion of step (b), the reaction medium is cooled to a temperature below 15°C, in particular below 10°C, in particular between 0°C and 5°C.
[0044] This cooling step is typically carried out after a vacuum distillation, preferably a vacuum azeotropic distillation of the reaction mixture as described above.
[0045] In one preferred embodiment, upon completion of step (b), the cooled reaction medium is allowed to separate by settling after addition of water to form an organic phase and a separate aqueous phase, which is then removed.
[0046] This operation is advantageously carried out several times, typically between 2 and 5 times, in particular 3 times.
[0047] The amount of water to be added is expressed, for example, between 0.1 and 2 vol.eq., based on the mass of butyrolactonic acid initially used. Note that if the butyrolactonic acid comes from step (a), the amount of water to be added is expressed relative to the mass of L-glutamic acid initially introduced, and the vol.eq. figure remains unchanged.
[0048] When separation by water addition / settling operation is carried out several times, the amount of water added in the first cycle is typically between 1 and 2 vol.eq., and the amount of water added in subsequent cycles is typically between 0.1 and 0.5 vol.eq.
[0049] The reaction medium obtained on completion of step (b), preferably the organic phase recovered after separation by water addition / settling operation, typically contains, as the main species, the 2-hydroxyglutaric acid diester of formula (II) and also the esterified lactone of formula (BR), advantageously in a mixture with the acetate ester of formula CH3COOR, in solution in alcohol ROH.
[0050] In one preferred embodiment, R corresponds to a butyl group (Bu) and the reaction medium obtained on completion of step (b), preferably the organic phase recovered after separation by water addition / settling, typically contains, as the main species, dibutyl 2-hydroxyglutarate of formula (BHG), and also butyrolactonic acid butyl ester of formula (BBE), advantageously in a mixture with butyl acetate CHCOOBu, in solution in butanol (BuOH). [ka]
[0051] In one preferred embodiment, the reaction medium obtained on completion of step (b), preferably the organic phase recovered after separation by water addition / settling operation, is then dehydrated by vacuum distillation at a pressure between 10 and 500 mbar, in particular between 10 and 350 mbar, preferably between 10 and 150 mbar, in particular between 50 and 100 mbar.
[0052] Advantageously, this is a vacuum azeotropic distillation of a water / ROH / CH3COOR mixture, in particular water / BuOH / CH3COOBu, from which the water can be removed.
[0053] In one preferred embodiment, the reaction medium obtained at the end of step (b), preferably the organic phase recovered after separation by water addition / settling operation, is dehydrated by vacuum distillation, advantageously at a pressure between 10 and 500 mbar, in particular between 10 and 350 mbar, preferably between 10 and 150 mbar, in particular between 50 and 100 mbar, and then concentrated under vacuum to remove some of the ROH / CH3COOR mixture, in particular BuOH / CH3COOBu, before being subjected to step (c).
[0054] The amount of the mixture removed is typically between 1 and 2 vol.eq., based on the mass of butyrolactonic acid originally used, or, if the butyrolactonic acid is that obtained from step (a), based on the mass of L-glutamic acid originally introduced.
[0055] In the following description, the previously mentioned operations of cooling, separation by addition of water / settling, dehydration by vacuum distillation, and / or concentration under vacuum, if performed, shall be considered as an integral part of step (b).
[0056] Steps (b) and (c) are preferably carried out in a one-pot embodiment, ie without intermediate steps of isolation or purification.
[0057] Step (c) Step (c) aims at forming the 2-bromoglutaric acid diester of formula (I) by bromination of the 2-hydroxyglutaric acid diester of formula (II) obtained in step (b).
[0058] As will be clear to those skilled in the art from the detailed description of step (b), the reaction medium obtained on completion of step (b) typically contains the 2-hydroxyglutaric acid diester of formula (II) as the main species, together with the esterified lactone of formula (BR), in solution in the alcohol ROH, advantageously in admixture with an acetate ester of formula CHCOOR.
[0059] Thus, although step (c) aims at the formation of the 2-bromoglutaric acid diester of formula (I) by brominating the 2-hydroxyglutaric acid diester of formula (II), the production of the 2-hydroxyglutaric acid diester of formula (II) by reaction of the esterified lactone of formula (BR) with the alcohol ROH can typically continue during this step, with the introduction of a brominating agent into the reaction medium making the ring opening of the lactone easier.
[0060] Step (c) is typically initiated by setting the temperature of the reaction medium to a value between 5°C and 40°C, advantageously between 10°C and 30°C, and in particular 20°C.
[0061] Gaseous hydrobromic acid is then slowly introduced into the reaction medium by sparging.
[0062] In one preferred embodiment, the amount of gaseous hydrobromic acid introduced is typically between 1 and 1.5 mol.eq., in particular between 1.2 and 1.3 mol.eq., based on the amount of butyrolactonic acid used in step (b) or based on the amount of L-glutamic acid initially introduced in step (a).
[0063] In one preferred embodiment, the reaction medium obtained after the introduction of gaseous hydrobromic acid is then dehydrated by vacuum distillation, typically at a pressure between 10 and 500 mbar, in particular between 10 and 350 mbar, preferably between 10 and 150 mbar, in particular between 50 and 100 mbar, typically for a period of 3 to 8 hours, advantageously 5 to 7 hours.
[0064] Advantageously, the vacuum distillation is a vacuum azeotropic distillation of a water / ROH / CH3COOR mixture, in particular of water / BuOH / CH3COOBu, from which water can be removed.
[0065] The temperature of the reaction medium is then returned to a value typically between 5°C and 40°C, advantageously between 10°C and 30°C, and in particular 20°C.
[0066] In one preferred embodiment, the aforementioned operating cycle, i.e., setting the temperature of the reaction medium to a value between 5°C and 40°C; introducing gaseous hydrobromic acid in an amount typically between 1 and 1.5 mol eq., based on the amount of butyrolactonic acid used in step (b) or based on the amount of L-glutamic acid initially introduced in step (a); removing water from the reaction medium by vacuum distillation over a period of 3 to 8 hours; and returning the temperature of the reaction medium to a value between 5°C and 40°C, is repeated 3 to 8 times, preferably 4 to 6 times.
[0067] The reaction medium obtained on completion of step (c) typically contains the 2-bromoglutaric acid diester of formula (I) in solution in alcohol ROH, advantageously in admixture with an acetate ester of formula CH3COOR.
[0068] In one preferred embodiment, R corresponds to a butyl group and the reaction medium obtained on completion of step (c) typically comprises dibutyl 2-bromoglutarate of formula (BBG) in solution in butanol BuOH, advantageously in a mixture with butyl acetate CHCOOBu.
[0069] Alternatively, hydrobromic acid can be generated in situ during azeotropic distillation. In this alternative, a salt of bromine, typically NaBr or KBr, is introduced into the reaction medium instead of gaseous hydrobromic acid, and then a strong acid, such as concentrated sulfuric acid (>96%), is added.
[0070] Those skilled in the art will know how to employ subsequent process treatment steps, particularly to remove salts that may be present, such as sulfates in this alternative embodiment.
[0071] Steps (d) to (e) In one preferred embodiment of the process according to the invention, the reaction mixture obtained on completion of step (c) is subjected to the following additional step: (d) introducing the reaction mixture obtained upon completion of step (c) into a basic aqueous solution (the solution so obtained typically has a pH between 7.5 and 9.5); (e) separating the solution obtained in step (d) by settling to form an organic phase and a separated aqueous phase, and then removing the aqueous phase; (f) concentrating the organic phase obtained in step (e) under vacuum until a temperature between 65°C and 75°C is reached, followed by drying under vacuum; (g) In some cases, by filtration, recovering the 2-bromoglutaric acid diester of formula (I).
[0072] In an alternative embodiment, steps (d) and (e) are not carried out, and the reaction mixture obtained upon completion of step (c) is directly subjected to step (f), optionally followed by a filtration step (g).
[0073] Step (d) may in particular be carried out by adding the reaction mixture obtained at the completion of step (c) to an aqueous solution of bicarbonate (also called hydrogen carbonate) ions, the amounts of potassium or sodium bicarbonate and water employed being determined by a person skilled in the art so that at the completion of step (d) the solution typically has a pH between 7.5 and 9.5, in particular between 8 and 9, allowing separation between the aqueous and organic phases during step (e).
[0074] The organic phase obtained in step (e), or the reaction mixture obtained on completion of step (c), is then concentrated in step (f) under vacuum, typically at a pressure of between 10 and 500 mbar, in particular between 10 and 350 mbar, preferably between 10 and 150 mbar, in particular between 50 and 100 mbar, until a temperature of above 50°C, in particular above 60°C, for example 70°C, is reached, to remove some of the ROH / CHCOOR mixture, and then dried under vacuum, typically at a pressure of between 10 and 350 mbar, preferably between 50 and 150 mbar, in particular between 50 and 100 mbar, until a temperature of above 50°C, in particular above 60°C, for example 70°C, is reached.
[0075] This step may be followed by a filtration step (g), which may be carried out using a variety of methods well known to those skilled in the art.
[0076] The process according to the invention makes it possible to obtain the 2-bromoglutaric acid diester of formula (I) in a yield of more than 85%, advantageously more than 90%, and with a purity, determined by HPLC analysis, of more than 90%, in particular more than 93%, typically more than 95%, preferably more than 97%, in particular more than 98%, advantageously more than 99%.
[0077] In one preferred embodiment, R corresponds to a butyl group and the process according to the invention makes it possible to prepare dibutyl 2-bromoglutarate of formula (BBG) in the yields and purities mentioned above.
[0078] The present invention therefore further relates to the following 2-bromoglutaric acid diesters of formula (I) having a purity of 90% or more, in particular 93% or more, typically 95% or more, preferably 97% or more, especially 98% or more and advantageously 99% or more, as determined by HPLC analysis: [ka] [wherein R represents a (C3-C6) alkyl group, preferably a butyl group]
[0079] Racemization Step The 2-bromoglutaric acid diester of formula (I) can be obtained in various enantiomeric excesses, and if it is not racemic, it can be racemized in an additional racemization step using bromine salts, such as LiBr or tetrabutylammonium bromide, according to methods well known to those skilled in the art. [Brief explanation of the drawings]
[0080] [Figure 1] This is the mass spectrum of BBG. DETAILED DESCRIPTION OF THE INVENTION
[0081] Example The following abbreviations are used:
[0082] [Table 1]
[0083] I: Synthesis of dibutyl 2-bromoglutarate I.1: Protocol 147.1 g (1 mol) of L-glutamic acid is dissolved in 294 g of water. The solution is heated to 55°C ± 5°C. 76 g (1.1 mol) of sodium nitrite dissolved in 152 g of water is gradually added. This contact is maintained at 55°C ± 5°C for at least 2 hours until dissolution is complete, and then the solution is cooled to 20-25°C. After neutralization with approximately 122 g (1.1 mol) of 33% hydrochloric acid, the medium is concentrated under vacuum (less than 100 mbar) while gradually increasing the temperature up to 60°C.
[0084] The butyrolactonic acid obtained is esterified with 370 g (5 mol) of butanol in the presence of 206 g of butyl acetate and 1.47 g (0.015 mol) of sulfuric acid under azeotropic distillation and under vacuum. The reaction medium is then cooled to 0-5°C and poured into 221 g of water. The lower aqueous phase is removed and the organic phase is washed twice more with 30 g of water. The organic phase obtained contains a mixture of butyl hydroxyglutarate / butyl ester of butyrolactone (HPLC s / s: 90 / 10). The mixture is dehydrated by azeotropic distillation under 50-100 mbar and concentrated by removing an amount corresponding to 195 g of solvent.
[0085] The bromination is carried out by carrying out the following operation five times in succession: sparging 100 g (1.2 mol) of hydrobromic acid under azeotropic vacuum at 20±10°C for at least 5 hours. The reaction medium is washed with an aqueous solution of 6 g of potassium bicarbonate dissolved in about 60 g of water. The aqueous phase is discarded and the organic phase is washed with water, then concentrated under vacuum until the temperature reaches about 70°C. BBG is obtained in a yield of 90% and with a purity of 97.1% s / s as determined by HPLC.
[0086] I.2: BBG Characterization - Boiling point: 115-120°C / 0.2-0.3 mmHg, i.e., approximately 380°C (atmospheric pressure). - NMR (performed on a JEOL 500MHz instrument): 1H NMR(CDCl3,400MHz)4.34-4.39(m,1H,Br-CH-COO),4.16-4.22(m,2H,Br-CH-COOCH2),4.06-4.11(m,2H,CH2-COOCH2),2.50-2.59(m,2H,OOC-CH2-CH 2-CHBr),2.25-2.43(m,2H,OOC-CH2-CH2-CHBr),1.55-1.69(m,4H,CH2-CH2-CH2),1.34-1.45(m,4H,CH3-CH2-CH2),0.92-0.96(m,6H,CH3-CH2-CH2) - Mass spectrometry The presence of bromine in the molecule was confirmed by mass spectrometry, performed using a Waters QDa mass spectrometer equipped with a Waters I-Class UHPLC instrument, recorded in positive electrospray mode with a cone voltage of 10 V. The resulting mass spectrum is shown in FIG. The doublet with a difference of 2 confirms the presence of bromine in the molecule. The mass at 323-325 corresponds to the parent peak, and the mass at 249-251 corresponds to the butoxide cleavage.
[0087] I.3.: HPLC analysis · Device: - The HPLC instrument consists of a pumping system, an injector, a chromatographic column, a UV detector, and a data station. - Spherisorb ODS 2, 250 x 4.6 mm - 5 μm column. - 96% sulfuric acid, Suprapur® (Merck, 1.00714 or equivalent). - Acetonitrile (HPLC gradient grade, JT Baker, ref. 8143 or equivalent). - Deionized water (Elga HPLC grade or equivalent).
[0088] · How: - Mobile phase: Route A: 100% acetonitrile Route B: 0.1% v / v aqueous sulfuric acid solution - Sample preparation: 0.2 g of the BBG to be analyzed is placed in a 20 mL volumetric flask followed by the addition of sufficient acetonitrile to make a 20 mL solution.
[0089] - Analysis conditions:
[0090] [Table 2]
[0091] - Gradient:
[0092] [Table 3]
[0093] II.: Racemization of dibutyl 2-bromoglutarate During the synthesis, the asymmetric carbon retains its configuration and is partially racemized during bromination. BBG is typically obtained with an enantiomeric excess ranging from 50% to 80%. If the resulting BBG is not racemic, it can be racemized using a bromine salt.
[0094] II.1.: Use of LiBr Racemization of BBG by contact with 1 mol% LiBr at 60°C for 2 hours Wash the racemic BBG with 2 x 2 weight equivalents of 0.1 M sodium bicarbonate solution at 25 °C.
[0095] Washing with 0.5 weight equivalents of water under vacuum (pressure: ≦30 mbar) at a reaction medium temperature ≦70° C.
[0096] This process was applied to 3418 g of BBG and 9.22 g of LiBr, giving a yield of 97.9%.
[0097] Chiral HPLC monitoring was performed to achieve racemization.
[0098] · Device: - HPLC instrument with UV detector. - Chiralpak IC-5μm-250×4.6mm column (Daicel)
[0099] · How: - Mobile phase: 95% heptane / 5% isopropyl alcohol - Sample preparation: 50 mg of the BBG to be analyzed is placed in a 10 mL volumetric flask followed by sufficient heptane to make a 10 mL solution. - Analysis conditions: Normal phase HPLC, mobile phase elution: isocratic mode.
[0100] [Table 4]
[0101] - Calculation of enantiomeric excess: %ee = (Peak area 1 - Peak area 2) / (Peak area 1 + Peak area 2) × 100
[0102] [Table 5]
[0103] II.2.: Use of TBAB It was found that racemization was possible with TBAB under the same conditions as with LiBr, without the use of a solvent, at room temperature.
[0104] 3.2 g of TBAB is added to 323 g of BBG. The medium is stirred for at least 5 hours until an ee of less than 1% is reached. TBAB is removed by washing twice with 150 mL of water in succession. BBG is concentrated under vacuum at a temperature of less than 70°C. Preferred embodiments of the present invention will be described below. Section 1. 1. A process for preparing a 2-bromoglutaric acid diester of formula (I):
change
change
change
change
Claims
1. 1. A process for preparing 2-bromoglutaric acid diester of formula (I): 【Chemistry 1】 [Wherein R is (C 3 ~C 6 ) represents an alkyl group] (b) reacting a butyrolactonic acid of formula (BA) with an alcohol of formula ROH in the presence of an acid to form a 2-hydroxyglutaric acid diester of formula (II); 【Chemistry 2】 【Transformation 3】 and (c) brominating the 2-hydroxyglutaric acid diester of formula (II) to the 2-bromoglutaric acid diester of formula (I) by sparging with gaseous hydrobromic acid; The process includes:
2. 2. The process of claim 1, wherein the acid in step (b) is sulfuric acid.
3. Step (b) is a compound of formula CH 3 3. The process according to claim 1 or 2, characterized in that it is carried out in the presence of an acetate ester of COOR.
4. 4. The process according to claim 1, wherein during step (b) water is removed by vacuum distillation.
5. The process of claim 4, wherein the vacuum distillation is a vacuum azeotropic distillation.
6. 6. The process according to claim 1, wherein in step (b) the butyrolactonic acid of formula (BA) and the alcohol ROH are introduced in amounts such that the molar ratio ROH / BA is between 2 and 10.
7. 7. The process according to any one of claims 1 to 6, characterized in that, on completion of step (b), the reaction medium in which step (b) has been carried out is cooled to a temperature below 15°C, water is added and then left to separate by settling to form an organic phase and a separated aqueous phase, which is then removed and the organic phase is dehydrated by vacuum distillation and / or concentrated under vacuum before being subjected to step (c).
8. The process of claim 1, wherein, upon completion of step (b), the reaction medium in which step (b) has been carried out is cooled to a temperature below 15°C, water is added thereto and allowed to stand to separate by settling to form an organic phase and a separated aqueous phase, the aqueous phase is then removed and the organic phase is dehydrated by vacuum azeotropic distillation and / or concentrated under vacuum before being subjected to step (c).
9. Step (c) comprises: - setting the temperature of the reaction medium in which step (c) is carried out between 5°C and 40°C; - introducing gaseous hydrobromic acid in an amount of between 1 and 1.5 mol. eq., based on the amount of butyrolactonic acid (BA) used in step (b), - removing water from the reaction medium by vacuum distillation; - returning the temperature of the reaction medium to between 5°C and 40°C, The process according to any one of claims 1 to 8, comprising a cycle of the steps:
10. the step of removing water comprises: removing water from the reaction medium by vacuum distillation for a period of 3 to 8 hours; 10. The process of claim 9.
11. 11. The process according to claim 9 or 10, characterized in that the cycle of steps is repeated 3 to 8 times.
12. In step (c), - removing water from the reaction medium by vacuum distillation, removing water from the reaction medium by vacuum azeotropic distillation; The process according to any one of claims 9 to 11.
13. 13. The process according to any one of claims 1 to 12, characterized in that it comprises a first step (a) of reacting L-glutamic acid with sodium nitrite in an aqueous solution to form butyrolactonic acid of formula (BA).
14. 2. The reaction mixture obtained upon completion of step (c) comprises: (d) introducing the reaction mixture obtained upon completion of step (c) into a basic aqueous solution; (e) separating the solution obtained in step (d) by settling to form an organic phase and a separated aqueous phase, and then removing the aqueous phase; (f) concentrating the organic phase obtained in step (e) under vacuum until it reaches a temperature between 65°C and 75°C, followed by drying under vacuum; (g) optionally filtering; and recovering the 2-bromoglutaric acid diester of formula (I); 14. The process according to any one of claims 1 to 13, characterized in that it is subjected to the additional step of:
15. 15. The process of claim 14, wherein the solution obtained in step (d) has a pH between 7.5 and 9.
5.
16. 16. The process according to any one of claims 1 to 15, characterized in that the 2-bromoglutaric acid diester of formula (I) obtained on completion of step (c), (f) or (g) is subjected to a further racemization step by adding a bromine salt.
17. 17. The process of claim 16, wherein the bromine salt is LiBr or tetrabutylammonium bromide.
18. 18. A process according to any one of claims 1 to 17, characterized in that R corresponds to an n-butyl group.
Citation Information
Patent Citations
Compounds Containing Short Aminoalcohol Chains and Metal Complexes for Medical Imaging
JP2009513574A
PCTA-based contrast agents
JP2021533165A
Compounds Comprising a Biological Target Recognizing Part, Coupled to a Signal Part Capable of Complexing Gallium
US20110092806A1
Method for producing novel nitrogen-containing compound or salt thereof, and production intermediate of same
WO2016153054A1
Gadolinium bearing PCTA-based contrast agents
WO2020030618A1